跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 822 条关于
“filgrastim-ayow”
全部
822
临床试验
675
药物
112
机构
0
资讯
35
4年前
FDA Approves Fylnetra, Fifth Biosimilar of Neulasta, for Febrile Neutropenia
11个月前
Amneal Submits BLA for Omalizumab Biosimilar to Challenge $4.1 Billion XOLAIR Market
2年前
FDA Approves Nypozi (filgrastim-txid) as Biosimilar to Neupogen
去年
Filgrastim Biosimilars Demonstrate $15 Million Cost Savings Potential in Cancer Care
去年
Ten-Year Study Confirms Long-Term Safety of Biosimilar Filgrastim in Healthy Stem Cell Donors
去年
CuraTeQ Biologics' Zefylti (Filgrastim Biosimilar) Receives Positive CHMP Opinion for EU Approval
去年
EMA's CHMP Recommends Approval of Six New Biosimilars
12个月前
Kashiv BioSciences and JAMP Pharma Launch Neutropenia Biosimilars in Canada
8个月前
Aurobindo Pharma's Dyrupeg Biosimilar Receives Health Canada Approval for Cancer Neutropenia Treatment
去年
Intas Pharmaceuticals and Accord BioPharma Acquire UDENYCA Biosimilar, Expanding Global Pegfilgrastim Market Presence
第 1 页,共 4 页
上一页
下一页